Enovis Corp

NYSE:ENOV  
59.87
+1.31 (+2.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.31B
Current PE12.95
Forward PE 27.85
2yr Forward PE 23.48
See more stats
Estimates Current Quarter
Revenue$439.17 Million
Adjusted EPS$0.47
See more estimates
10-Day MA$58.42
50-Day MA$58.40
200-Day MA$100.90
See more pivots

Enovis Corp Stock, NYSE:ENOV

2711 Centerville Road, Suite 400, Wilmington, Delaware 19808
United States of America
Phone: +1.302.252.9190
Number of Employees: 16200

Description

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.